BiotechTube
Home/BlueHaven Therapeutics/Michael Dornish
MD

Michael Dornish

Co-founder and Chief Scientific Officer

BlueHaven Therapeutics

Therapeutic Areas

Oncology

BlueHaven Therapeutics Pipeline

DrugIndicationPhase
Lead Program (unspecified)Glioblastoma (GBM)Preclinical

Leadership Team at BlueHaven Therapeutics

MG
Marco G. Renoldi
Chief Executive Officer
JD
Jostein Dahle
Co-founder and Chief Technology Officer
LS
Luca Sereni
Co-founder and Chief Operating Officer
SP
Stefania Poli
Chief People Officer
View full BlueHaven Therapeutics profile